Mycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
LADR GmbH MVZ Dr. Kramer und Kollegen, Geesthacht, Germany.
Clin Infect Dis. 2021 Mar 12;72(Suppl 2):S109-S113. doi: 10.1093/cid/ciaa1836.
The EORTC/MSGERC have revised the definitions for proven, probable, and possible fungal diseases. The tissue diagnosis subcommittee was tasked with determining how and when species can be determined from tissue in the absence of culture. The subcommittee reached a consensus decision that polymerase chain reaction (PCR) from tissue, but not immunohistochemistry or in situ hybridization, can be used for genus or species determination under the new EORTC/MSGERC guidelines, but only when fungal elements are identified by histology. Fungal elements seen in tissue samples by histopathology and identified by PCR followed by sequencing should fulfill the definition of a proven fungal infection, identified to genus/species, even in the absence of culture. This summary discusses the issues that were deliberated by the subcommittee to reach the consensus decision and outlines the criteria a laboratory should follow in order to produce data that meet the EORTC/MSGERC definitions.
EORTC/MSGERC 修订了确诊、疑似和可能真菌感染的定义。组织诊断小组委员会负责确定在没有培养物的情况下如何以及何时可以从组织中确定物种。小组委员会达成共识,认为聚合酶链反应(PCR)可用于组织,但不能用于免疫组织化学或原位杂交,根据 EORTC/MSGERC 新指南可以用于属或种的确定,但前提是组织中必须通过组织学识别出真菌成分。通过组织病理学观察到的组织样本中的真菌成分,并通过 PCR 后测序鉴定,应符合确诊真菌感染的定义,鉴定到属/种,即使没有培养物。本摘要讨论了小组委员会为达成共识所审议的问题,并概述了实验室应遵循的标准,以生成符合 EORTC/MSGERC 定义的数据。